Tanya Ho

The voices are coming definitive about the need of a supportive Singapore stock exchange for startups. One of Singapore's legendary investors Boon Hwee Koh, who also happens to be the chairman of SGX, chimes in. In his letter to SGX shareholders, he explained that "Should [SGX} fail to enable venture capital and private equity to exit their investments and recycle the capital deployed, the supply of such capital will eventually dry up and threaten the start-up ecosystem that Singapore has built and nurtured over the past decades." In the past 20 years, startups operated independently of the SGX, where trade sales and US IPOs were the norm for exits. But it is timely for an alignment together with the SGX, in order for the Singapore startup ecosystem to evolve and survive. #venturecapital #sgx #startupsg https://lnkd.in/gAqZ9st9

17

2 Comments

As a venture capitalist, TRIVE's focus is on exits for my SouthEast Asian based portfolios, and IPOs are one of the main avenues to achieve an exit and a return on my investments. 5 of our startups are considering their IPO plans in the coming 3 years. After advisory from the M&A advisors and internal consideration, the NASDAQ is the choice for 4 of 5 of them. Only one decided on the local SGX as it is on a more traditional path. Nevermind if these startups are primarily operating in SEA and naturally should find familiarity with SGX to list. Unfortunately, they see better valuations, liquidity and brand recognition by listing on the NASDAQ. It has been a long-time complex issue to energize the SGX and to ask our SEA startups to call it home. It is a pity because Singapore is the prime location for private equity and venture capital fundraise for startups in the region. But SGX barely sees any of our SEA unicorns listed on it. I for one, am a believer of a regional bourse to support the aspirations of the startups. And I hope more deeper conversations with the Singapore government and our relevant associations will one day see the SGX building that vision. Thanks to See Kit Tang for a very insightful long-form article and allowing me to be a part of it to bring my thoughts to it. #venturecapital #sgx #ipo https://lnkd.in/g_kzvyGa

27

We believe that 2025/26 will see a resurgence of new generation of fintech and financial innovation opportunities across the economies of #SEAsia and #India. As open data architecture, digital public Infra, cross border solutions, financial innovation across verticals, and digital evolution of SMEs reshape the real economies, we believe that new business models will be born and prevail. Taka Yamada Varun Malhotra Satvik B. Disha Soni Rachel Teow

44

Bank of Singapore’s 2024 Supertrends report offers a valuable roadmap for navigating the challenges and opportunities of a world in transition. Read our full report here: https://lnkd.in/gu3gJGgt

175

1 Comment

Today, we are excited to share that Anapi has created a high value yet low-cost healthcare insurance product specifically for Singapore based solopreneurs and startups with ONE or more employee headcount as part of the take up eligibility criteria. For months, we have been having conversations with Andrew Lai and Gabriel Tay Zhichao from Anapi to launch this product. We are grateful that they share our passion for driving impact and supporting fellow entrepreneurs on their journey. This new product, priced at approximately S$300 per year, provides coverage for basic inpatient benefits, four paid GP visits and 3 telemedicine consults. There is also an option to top up for specialist coverage… Hurray! We understand that entrepreneurship is tough. And in addition to that, in life, there are always unforeseen circumstances. We are confident that with this product, you and your team members can enjoy peace of mind - be taken care of by quality doctors and recover quickly, whilst balancing a tight P&L and budget. Afterall, a healthy team is a productive team. Cheers to business growth and expansion! Find out more about the insurance plan here: https://lnkd.in/g84Pz3SH To apply for the product, simply fill up the brochure and email [email protected] or book a meeting with anapi at https://lnkd.in/gQF5bPJD. This is just the beginning. If you're interested in working together and positively impact entrepreneurs, please reach out to us at [email protected]. We can’t do anything impactful alone - join us to build the SEA startup ecosystem hand in hand. #insurance #protection #startupsg

18

What has changed for medical investment in China during this “Capital Winter”? I was in Korea last week but didn’t miss out on the Gaorong Capital高榕资本’s Annual Healthcare CEO Conference & Demo Day in Shanghai. It’s a close-door event hosted by Gao Rong, a leading VC in China, attended by representatives from their healthcare portfolio companies, LPs, and other investment partners. It was a great opportunity to share my thoughts on why Chinese healthcare innovators need a mindset shift to achieve their Go Global aspirations. It was also a valuable learning experience for me. Here are a few takeaways from the event: 1️⃣ New Opportunities in the “Capital Winter”: While people are talking about the "capital winter" in China, funding is still available there, and it's still more substantial compared to many other parts of the world. However, new IPO regulations have made exits significantly harder, leading investors to become more cautious and selective. They are increasingly exploring alternative opportunities, such as overseas deals and acquisitions of corporate assets. 2️⃣ Survival of the Fittest: Biotech companies that once saw big investments in China are now facing tough times for the subsequent rounds due to IPO challenges. Only those with strong resilience and adaptation are likely to survive, while others may disappear. This may not be a bad thing, as it's a natural process to eliminate excess and encourage more rational competition. 3️⃣ Increased Focus on Commercial Viability: With IPOs becoming difficult, investors are paying more attention to the commercial growth of their companies. They’re helping with business development, fundraising, and even global expansion. No one knows how long this "winter" will last, but investors are finding creative ways to support their portfolio companies and each other.  🌍 It’s all about adapting and staying strong! To all the Chinese healthcare investors and innovators out there – 加油! #Healthcare #Investment #Biotech #BusinessGrowth #China

68

1 Comment

[Hasangyong met: John Yang, director of Riverwood Capital] There was a meeting to explore opportunities for local start-up teams to enter the global market. At the Invest Korea Summit 2024 event held at COEX in Seoul, I met John Yang, the director of Riverwood Capital Asia. It could have been awkward, but since I had already met my wife, it was my first smooth meeting. John Yang is in charge of Asia for a large investment company that conducts Series C and D investments in Silicon Valley, and as a Korean investor, he was very interested in Korean companies. Through this meeting, we introduced the current status of artificial intelligence and future mobility industries, which are specialized industries in Gwangju, and promised to discuss more specific cooperation measures in the future. "Efforts to create Gwangju with a high success rate for start-ups will continue." <Riverwood Capital> Riverwood Capital has created a $1.8 billion (W2.33 trillion) fund. Riverwood will invest in high-growth mid-sized technology companies, with most of the new capital going into new investments, not follow-up ones. Riverwood, a growth-stage investor, mainly invests between $25 million and $100 million per company and invests in 20-30 companies per fund cycle. It has so far made more than 75 investments, with GoPro and Nextdoor among its investment companies successfully listed, and Forge Rock recently sold to a private equity fund.

3

Kok Song NG and I had breakfast with David Su , founder and managing partner at Matrix Partners China, a venture capitalist, David focuses on software, technology and healthcare investments. He also cofounded San Si Institute, a community of entrepreneurial leaders who are committed to tackle big societal challenges. David who is a graduate of NTU, helps serve on boards of Nanyang Technological University Singapore ,CapitaLand & EDBI Pte Ltd ,has been investing in China for the last two decades , some investments include DiDi , Baidu, Inc. , Focus Group , Heptagon, Bona Films +++++. Was great to chat about geopolitics, Chinese (H share) equity markets, global macro, foreign exchange and about Chinese history. Some of these heavy conversations are best had with roti prata and a cup of coffee ! #venture #vc #venturecapital #geopolitics #macro #globalmacro #policy #healthcare #tech #technology #investments #medtech #biotech #deeptech

107

3 Comments

SGX needs “a flush of liquidity”, says Loke Wai San, the chairman of chip-tester AEM Holdings who famously led the company from its low share price of 7 cents to more than $5. As a co-founder of local private equity firm Novo Tellus, Loke helped AEM build up a strong institutional following, including securing Temasek as its single-largest investor with a stake of 12.5%. Loke is also known for launching one of the three spacs, known as blank-cheque listings, on SGX, although the potential of this would be unfulfilled as global market interest began to wane by the time the necessary processes were completed and SGX welcomed the three spacs. While he recognises that launching the spac was a form of risk-taking on his end, he adds that the capital market has to be welcome of risks, especially if investors desire something innovative with high equity. Read more: https://lnkd.in/gJZu5YUV #TheEdgeSG #finance #Investing #MarketTrends #GlobalMarkets #FinancialNews #EconomicGrowth #REITs #venturecapital #innovation #capitalmarkets #techgrowth #funding #startups

2

1 Comment

Kenny Shui, Vice President cum Co-Head of Public Policy Institute, 團結香港基金 Our Hong Kong Foundation (OHKF), Alex Mak, CFA, CESGA, Researcher, OHKF, and Cyrus Hou Yeung Ho, Assistant Researcher, OHKF, stated the challenges of technological upgrading and restructuring faced by many small and medium enterprises (SMEs) in developing artificial intelligence (AI).   How can SMEs source and train the technology professionals they need? Do the Government's subsidies for SMEs facilitate enterprises' investment in AI development? What strategies can the Government adopt to enhance the local AI ecosystem?   Read more: https://bit.ly/4exquD2

6

1 Comment

We're excited to share our latest whitepaper "The WealthTech Opportunity for Digital Brokerages" - a comprehensive study revealing how affluent investors are leveraging technology to optimise their investment strategies. Key insights from our research collaboration with distinguished academics Prof. Ben Charoenwong (INSEAD) and Prof. Alan Kwan (HKU Business School): 🔍 In-depth analysis of 800+ investors across Singapore and Hong Kong 💡 Deep dive into investment preferences of high-net-worth individuals 🚀 Exploration of emerging WealthTech trends in Asia 📊 Detailed examination of digital wealth management adoption The findings are clear: today's sophisticated investors are embracing digital solutions for their wealth management needs. This presents an unprecedented opportunity for innovative digital investment platforms to shape the future of wealth management. Download our whitepaper to explore how technology is transforming the investment landscape for high-net-worth individuals: https://lnkd.in/gqdFJYku #WealthTech #WealthManagement #MoomooSG

8

Today’s announcement has been months in the making. I’m very happy to share a significant milestone for VentureBlick in Singapore: our appointment as an official programme partner of the Startup SG Accelerator programme! 🇸🇬   In my decades long healthcare career, I’ve witnessed firsthand the struggles faced by startups in this space.   It’s not just about having a groundbreaking idea; it’s about navigating the complex landscape, finding the right resources, and most crucially, connecting with the right people.   Many startups need more than just guidance; they need someone to hold their hand through the journey and make those meaningful connections that can push them forward.   That’s precisely what we aim to do for healthcare at VentureBlick, and that’s what Startup SG aims to do for Singapore startups.   VentureBlick’s appointment as a programme partner of the Startup SG Accelerator’s programme partner network is a testament to our dedication to fostering innovation and driving real, tangible impact in the healthcare sector.   We’re on a mission to enable healthcare entrepreneurs to not just dream big but to turn those dreams into reality.   To all the visionary entrepreneurs out there, remember: you’re not alone in this journey. 💪🏼   Startup SG is an initiative of Enterprise Singapore. Thank you Enterprise Singapore, for placing your trust in us. 💚   #VentureBlick #HealthcareInnovation #Partnership

130

21 Comments

"China’s economy, like every other victim, subsequently entered into a liquidity trap or balance sheet recession. Private firms and households hunkered down, decreased economic activity, and saved money in order to repair their balance sheets. When credit demand falls amongst households and businesses, the standard-issue Keynesian economic medicine – i.e., running a modest fiscal deficit and lowering the price of money via central bank policy rate cuts – is ineffective. What is needed to forestall the dreaded deflation is a monetary and fiscal bazooka. The time it takes to switch into panic mode depends on a country’s culture. But make no mistake – regardless of the economic “-ism” supposedly practiced, every country always comes around to injecting monetary chemotherapy. I refer to this palliative treatment as chemotherapy because while it might cure the deflationary cancer, it ultimately kills the host. The host is the middle and lower classes, who are ravaged by asset price inflation with no discernible improvement in the real economy. And like modern oncology, this ultimately ineffective monetary chemotherapy is extremely profitable for a small cabal of financial witch doctors whose head offices are in New York, London/Paris/Frankfurt, Tokyo, and now possibly Beijing/Shanghai. Chinese people are some of the most resourceful people on this planet. They will not allow their precious yuan savings to sit idle as Beijing encourages asset price inflation. Bitcoin is not a foreign concept to middle and high income coastal urban dwellers. While the exchanges were barred from offering a visible Bitcoin/CNY trading pair, Bitcoin and crypto still flourishes in China." https://lnkd.in/g_eRxaNk

1

"Quite a lot of personal breakthroughs with finexis and my mentors here" - Hui Yu, Associate Director Hui Yu Ten achieved Top of the Table (TOT) for the year 2024 🏆 Discover her inspiring stories and how she has helped clients achieve their goals. Follow her to stay updated on her financial advisory journey! #FinanceSuccess #TOT2024 #CareerJourney #finexis #finexisadvisory #singapore #ourfinexisstory

12

Two sections from the three-part playbook are now available online. It provides an overview of Singapore’s Scope 2-related emissions and the role of the private sector in reducing carbon emissions.

1

🌏 Temasek's Global Investment Strategy Revealed! Curious about how one of the world's largest investment companies operates? Alpin Mehta, Head, Real Estate, and Deputy Head, Private Equity Fund Investments shares: • The 4 key structural trends shaping Temasek's investments • Why the US remains an attractive market • Temasek's bullish stance and cautious approach • How they balance long-term vision with adaptability • Insights into their portfolio reshaping strategy Dive into the mind of a global investor and gain valuable insights for your own investment approach! Catch the full episode: YouTube: https://lnkd.in/grVSRfK8 Spotify: https://lnkd.in/g4gPPPkW Apple: https://lnkd.in/gsB78PjC #InvestmentStrategy #GlobalMarkets #Temasek #TheFinancialCoconut #Investing

3

#Singapore drives #HealthTech funding across emerging markets! Emerging markets saw an average deployment of $36M per investor across the top 10 HealthTech backers, compared to an average of $148M in FinTech and $6.3M in Real Estate. #SoutheastAsian investors showed a clear dominance over the space, accounting for 30% of overall HealthTech funding with SeaTown Holdings International leading the charge. #Saudi-based BSF stood out as the lone MENA-based player on the list, while #Singapore claimed three out of ten spots. Learn all about this dynamic space in our full #HealthTech report: https://lnkd.in/dSWtcrDN #venturecapital #startups #funding #healthcare

13